GRANDE, VERA
GRANDE, VERA
DIPARTIMENTO DI MEDICINA, CHIRURGIA E ODONTOIATRIA (attivo dal 01/01/1999 al 26/04/2012)
A mouse LAM model by endonasal administration of human TSC2 deficient smooth muscle cells
2010 E. Lesma, E. Chiaramonte, S. Ancona, V. Grande, A.M. Di Giulio, A. Gorio
An epigenetic event may underlies the TSC features in TSC2 ASM cells
2009 E. Lesma, S. Ancona, S.M. Sirchia, V. Grande, E. Chiaramonte, S. Bosari, A.M. Di Giulio, A. Gorio
Anti-EGFR antibody efficiently and specifically inhibits human TSC2-/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM
2008 E. Lesma, V. Grande, S. Ancona, A.M. Di Giulio, A. Gorio
Anti-EGFR Antibody Efficiently and Specifically Inhibits Human TSC2-/- Smooth Muscle Cell Proliferation. Possible Treatment Options for TSC and LAM
2008 E. Lesma, V. Grande, S. Ancona, S. Carelli, A.M. Di Giulio, A. Gorio
Characterization of LAM/TSC cells isolated from patient chylous
2010 E. Lesma, S. Ancona, V. Grande, S.M. Sirchia, E. Chiaramonte, S. Bosari, A.M. Di Giulio, A. Gorio
Development of a LAM model by using human TSC2 deficient smooth muscle cells derived from a renal angiomylipoma
2010 E. Lesma, E. Chiaramonte, V. Grande, S. Ancona, A.M. Di Giulio, A. Gorio
Development of a LAM model by using human TSC2-/- cells derived from a renal angiomyolipoma : A pharmacological evaluation
2008 E. Lesma, E. Isaia, S. Ancona, V. Grande, A.M. Di Giulio, A. Gorio
Exploring the role of MKK7 in excitotoxicity and cerebral ischemia : a novel pharmacological strategy against brain injury
2015 A. Vercelli, S. Biggi, A. Sclip, I.E. Repetto, S. Cimini, F. Falleroni, S. Tomasi, R. Monti, N. Tonna, F. Morelli, V. Grande, M. Stravalaci, E. Biasini, O. Marin, F. Bianco, D. di Marino, T. Borsello
Expression of the anti-apoptotic protein survivin amd altered function of IGF-1 pathway in TSC2 brain tubers
2007 V. Grande, E. Lesma, E. Isaia, L. Madaschi, M.P. Canevini, L. Tassi, A.M. Di Giulio, A. Gorio
Farmacologia
2008 E.A. Lesma, A. Gorio, D. Bottai, S. Carelli, V. Grande, A.M. Di Giulio
G protein-mediated signal transduction is affected in primary biliary cirrhosis
2006 E.A. Lesma, V. Grande, A.M. Di Giulio, P. Castellana, A. Crosignani, A. Cerri, A. Gorio
Human smooth muscle TSC2-/- cells cause lymphangiogenesis-like lung destruction in nude mice. Pharmacological repair
2009 E. Lesma, E. Chiaramonte, S. Ancona, V. Grande, R. Adami, A.M. Di Giulio, A. Gorio
Isolation and growth characterization of two types of human TSC2 gene-deficient cells
2005 E. Lesma, S. Carelli, D. Vandoni, V. Grande, S. Bosari, M.P. Canevini, D. Brancaccio, A.M. Di Giulio, A. Gorio
Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma : epidermal growth factor is the required growth factor
2005 E.A. Lesma, V. Grande, S. Carelli, D. Brancaccio, M.P. Canevini, R.M. Alfano, G. Coggi, A.M. Di Giulio, A. Gorio
Molecular characterization of growth and survival of human TSC2 gene-deficient smooth muscle-like cells
2006 E. Lesma, V. Grande, S. Carelli, A.M. Di Giulio, A. Gorio
Pathogenesis and pharmacological evaluation of human TSC2 smooth muscle cells. Possible treatment options for TSC and lymphangioleiomyomatosis
2009 E. Lesma, V. Grande, S. Ancona, E. Chiaramonte, S.M. Sirchia, A.M. Di Giulio, A. Gorio
PATHOGENESIS AND PHARMACOLOGY OF ISOLATED HUMAN TSC2 SMOOTH MUSCLE CELLS. NOVEL THERAPEUTIC PERSPECTIVES
2006 A. Gorio, E. Lesma, V. Grande, E. Isaia, A.M. DI GIULIO
Pharmacological and biochemical characterization of isolated and in vitro grown human TSC2 gene-deficient smooth muscle-like cells
2005 E. Lesma, S. Carelli, V. Grande, D. Vandoni, S. Bosari, R. Chifari, A.M. Di Giulio, A. Gorio
Pharmacological reversion of the phenotype of human TSC2-/- smooth muscle cells
2006 V. Grande, E. Lesma, A.M. Di Giulio, A. Gorio
Phenotype reversion of human TSC2-/- smooth muscle cells
2007 E. Lesma, V. Grande, E. Isaia, A.M. Di Giulio, A. Gorio